🇺🇸·1d agoIndustry
Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVAâ„¢ Robotic Surgical System
Error code: 0.615ed617.1784849719.6873a6d5
Publisher
J
Johnson & Johnson News
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Johnson & Johnson News
- Region
- USA
- Scope
- Industry
- Published
- July 22, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Error code: 0.615ed617.1784849719.6873a6d5
Source route
Continue on jnj.com
Leave the platform to read the original full article on the publisher site.
Source: Johnson & Johnson News
Scope: Industry
Related coverage
More related coverage
AbbVie News/6h ago
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody® CD3xCD20) in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Certara/6h ago
Important drug development questions that model-based meta-analysis answers
Interpharma Switzerland/8h ago
3 Fragen an Adrian Cuadra Leon, General Manager von UCB ALPS (Austria & Switzerland)
Codexis/6h ago